Geneva, June 4 -- International Clinical Trials Registry received information related to the study (TCTR20250525008) titled 'Antibody Persistence at 2 and 3 Years after Immunization with a Recombinant Pertussis Booster Dose in Adults and Elderly' on May 25.
Study Type: Observational
Primary Sponsor: Chulalongkorn University
Condition:
Pertussis vaccine
Pertussis vaccine
Pertussis vaccine
Intervention:
Participants who received BioNet aP vaccine in the initial TDA206 study,Participants who received BioNet TdaP vaccine in the initial TDA206 study,Participants who received License aP vaccine in the initial TDA206 study,Participants who received License TdaP vaccine in the initial TDA206 study,Participants who received License Tdap vac...